From Our Thought Leaders

Human-Centric AI: Accelerating Formulation Development Without Compromising Trust

As artificial intelligence becomes increasingly embedded in formulation science and early clinical planning, the industry faces a dual challenge: accelerating timelines while safeguarding scientific rigor, patient safety, and regulatory trust. In thi... Read more

04 March, 2026 | Wednesday | Expert Opinion
Redefining CNS Therapeutics: A Conversation with Joel Latham on Incannex Healthcare’s Clinical Vision

    Under the leadership of Joel Latham, Incannex Healthcare is advancing a differentiated pipeline of cannabinoid- and psychedelic-based therapeutics targeting significant unmet needs in sleep disorders, inflammatory disease, and anxiety... Read more

02 March, 2026 | Monday | Interaction
Designing Decarbonization: Embedding Sustainability at the Core of Life Sciences Infrastructure

As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperative. From decarbonizing complex global supply chains to embedding environmental governance into... Read more

02 March, 2026 | Monday | News
Integrated Partnerships for Enabling Agility in Biologics Development

As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations (CDMOs) and their clients determines the program efficiency, outcome quality, and supply reliab... Read more

02 March, 2026 | Monday | Opinion

Bio Finance

Waters Expands into Global Diagnostics and Biosciences Powerhouse with BD Transaction Close

  Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications Announces formation of four divisions: Waters Analyti... Read more

11 February, 2026 | Wednesday | News
Sharp Sterile Advances Global Growth Strategy With $28M Lee Facility Expansion

Sharp Sterile Manufacturing has  announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will strengthen opportunities for highly skilled engineering and pharmaceutical manufacturing roles wi... Read more

09 January, 2026 | Friday | News

Contract Services

Former BioDuro Leadership Launches Forma Life Sciences as Independent CDMO

-Forma Life Sciences, Inc. announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product m... Read more

05 March, 2026 | Thursday | News
Integrated Partnerships for Enabling Agility in Biologics Development

As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations (CDMOs) and their clients determines the program efficiency, outcome quality, and supply reliab... Read more

02 March, 2026 | Monday | Opinion

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close